Baillie Gifford's position in Moderna is currently worth $5.24 Billion. That's 4.12% of their equity portfolio (5th largest holding). The investor owns 11.14% of the outstanding Moderna stock. The first Moderna trade was made in Q4 2018. Since then Baillie Gifford bought shares thirteen more times and sold shares on eight occasions. The investor's estimated purchase price is $5.68 Billion, resulting in a loss of 7.8%.